LEXARIA BIOSCIENCE CORP.: 10-Q filed 2015-07-14
What LEXARIA BIOSCIENCE CORP. reported in its quarterly report filed 2015-07-14 (fiscal Q3 2015): 27 published measures, 76 facts as tagged in accession 0001062993-15-003829.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-07-14
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001062993-15-003829 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LEXARIA BIOSCIENCE CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 1,198,851 | USD | |
| At 2014-08-31 | 2,635,136 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 62,604 | USD | |
| At 2014-08-31 | 918,038 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 1,152,308 | USD | |
| At 2014-08-31 | 1,717,098 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 832,101 | USD | |
| At 2014-08-31 | 703,030 | USD | |
| At 2014-05-31 | 877,886 | USD | |
| At 2013-08-31 | 65,542 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-01 to 2015-05-31 | -920,138 | USD | 273 |
| 2013-09-01 to 2014-05-31 | -969,498 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-01 to 2015-05-31 | 368,358 | USD | 273 |
| 2013-09-01 to 2014-05-31 | 1,701,800 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-01 to 2015-05-31 | 680,851 | USD | 273 |
| 2013-09-01 to 2014-05-31 | 80,042 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | -9,570,059 | USD | |
| At 2014-08-31 | -8,315,389 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | 68,061 | USD | 92 |
| 2014-09-01 to 2015-05-31 | 242,781 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 0 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 0 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 1,157,896 | USD | |
| At 2014-08-31 | 2,567,474 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | 0 | USD | 92 |
| 2014-09-01 to 2015-05-31 | 31,544 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 53,123 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 161,617 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 62,604 | USD | |
| At 2014-08-31 | 918,038 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 21,632 | USD | |
| At 2014-08-31 | 97,003 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | 508,504 | USD | 92 |
| 2014-09-01 to 2015-05-31 | 1,366,015 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 527,680 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 797,156 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 79,344 | USD | |
| At 2014-08-31 | 0 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | -2,504 | USD | 92 |
| 2014-09-01 to 2015-05-31 | -1,673 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 0 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 0 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | 9,691 | USD | 92 |
| 2014-09-01 to 2015-05-31 | 11,743 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 0 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 0 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | 107 | USD | 92 |
| 2014-09-01 to 2015-05-31 | 48,386 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 0 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 0 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 39,682,984 | shares | |
| At 2014-08-31 | 34,249,690 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 10,683,185 | USD | |
| At 2014-08-31 | 10,033,438 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 1,136,247 | USD | |
| At 2014-08-31 | 1,717,098 | USD | |
| At 2013-10-31 | 2,098,903 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-05-31 | 224,819 | USD | |
| At 2014-08-31 | 367,441 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | -511,008 | USD | 92 |
| 2014-09-01 to 2015-05-31 | -1,318,770 | USD | 273 |
| 2013-11-01 to 2014-08-31 | -3,257,712 | USD | 304 |
| 2014-03-01 to 2014-05-31 | -437,996 | USD | 92 |
| 2013-09-01 to 2014-05-31 | -639,938 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | -467,506 | USD | 92 |
| 2014-09-01 to 2015-05-31 | -1,254,670 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 0 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 0 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-03-01 to 2015-05-31 | 8,735 | USD | 92 |
| 2014-09-01 to 2015-05-31 | 19,785 | USD | 273 |
| 2014-03-01 to 2014-05-31 | 7,040 | USD | 92 |
| 2013-09-01 to 2014-05-31 | 8,218 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-01 to 2015-05-31 | -75,371 | USD | 273 |
| 2013-09-01 to 2014-05-31 | -30,675 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-01 to 2015-05-31 | 79,344 | USD | 273 |
| 2013-09-01 to 2014-05-31 | 0 | USD | 273 |
Inspect the source
- Entity
- LEXARIA BIOSCIENCE CORP. / CIK 0001348362
- Captured
- 2026-09-20T07:55:03.045Z
- SEC response SHA-256
c8696dbfbdb8ee1a7522ea5b45a8c2d45cb12720b3d84857c1cda6bba2861389
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001348362.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))